Patent number: 5663362
Abstract: The invention relates to novel substituted triazolinones of the general formula (I), ##STR1## in which R.sup.1 represents hydrogen, halogen, cyano, hydroxyl or one of the radicals --R.sup.6, --O--R.sup.6, --O--NR.sup.6 R.sup.7, --S--R.sup.6, --S(O)--R.sup.6 or --SO.sub.2 --R.sup.6,R.sup.2 represents hydrogen, hydroxyl, amino, cyano or one of the radicals --R.sup.6, --O--R.sup.6 or --N.dbd.CR.sup.6 R.sup.7,R.sup.3 represents hydrogen, halogen, alkyl or halogenoalkyl,R.sup.4 represents hydrogen, one of the radicals --R.sup.6, --O--R.sup.6 or --SO--R.sup.6 or an inorganic or organic cation andR.sup.5 represents amino, hydroxyl or one of the radicals --R.sup.6 or --NR.sup.6 R.sup.7, orR.sup.4 and R.sup.5 together represent a divalent alkanediyl radical andX represents oxygen or sulphur, whereR.sup.6 represents alkyl, alkenyl, alkinyl, cycloalkyl, aryl or heterocyclyl, which may each optionally be substituted,R.sup.
Type:
Grant
Filed:
June 6, 1995
Date of Patent:
September 2, 1997
Assignee:
Bayer Aktiengesellschaft
Inventors:
Wilhelm Haas, Karl-Heinz Linker, Otto Schallner, Kurt Findeisen, Hans-Joachim Santel, Markus Dollinger